There are 2867 resources available
773P - Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy
Presenter: Hasan Yildirim
Session: Poster session 14
774P - Immune checkpoint inhibitor monotherapy and the risk of venous thromboembolism in cancer: A systematic review and meta-analysis
Presenter: Nihal Khan
Session: Poster session 14
775P - Treatment of Kaposi sarcoma with immune-checkpoint inhibitors: A systematic review and single-arm meta-analysis
Presenter: Maysa Silveira Vilbert
Session: Poster session 14
776P - Early mortality in patients with cancer treated with immunotherapy in routine practice
Presenter: Jacques Raphael
Session: Poster session 14
777TiP - Phase I study of LYL797, a ROR1-targeted CAR T-cell therapy with genetic and epigenetic reprogramming for the treatment of advanced solid tumors
Presenter: David Spigel
Session: Poster session 14
778TiP - A phase I/II trial investigating safety and efficacy of autologous TAC T-cells targeting HER2 in relapsed or refractory solid tumors
Presenter: Benjamin Schlechter
Session: Poster session 14
779TiP - Commencement of first-in-human phase I/II TCR-T clinical trial targeting shared tumor-specific hotspot mutations in solid tumors
Presenter: Maria Pia Morelli
Session: Poster session 14
782TiP - Reduced frequency immune checkpoint inhibition in cancers (REFINE): A multi-arm phase II trial testing reduced intensity immunotherapy in different cancers
Presenter: Sophie Merrick
Session: Poster session 14